» Articles » PMID: 32083000

Long Non-coding RNA in Gastrointestinal Cancer

Overview
Journal Front Oncol
Specialty Oncology
Date 2020 Feb 22
PMID 32083000
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Whole genome and transcriptome sequencing technologies have led to the identification of many long non-coding RNAs (lncRNAs) and stimulated the research of their role in health and disease. LncRNAs participate in the regulation of critical signaling pathways including cell growth, motility, apoptosis, and differentiation; and their expression has been found dysregulated in human tumors. Thus, lncRNAs have emerged as new players in the initiation, maintenance and progression of tumorigenesis. (plasmacytoma variant translocation 1) lncRNA is located on chromosomal 8q24.21, a large locus frequently amplified in human cancers and predictive of increased cancer risk in genome-wide association studies (GWAS). Combined, colorectal and gastric adenocarcinomas are the most frequent tumor malignancies and also the leading cause of cancer-related deaths worldwide. expression is elevated in gastrointestinal tumors and correlates with poor patient prognosis. In this review, we discuss the mechanisms of action underlying oncogenic role in colorectal and gastric cancer such as upregulation, miRNA production, competitive endogenous RNA (ceRNA) function, protein stabilization, and epigenetic regulation. We also illustrate the potential role of as prognostic biomarker and its relationship with resistance to current chemotherapeutic treatments.

Citing Articles

Development of a T cell engaging bispecific antibody targeting long non-coding RNA PVT1.

Kato H, Tsukahara T, Murata K, Nishikata H, Mizue Y, Sasaya T Cancer Immunol Immunother. 2025; 74(4):133.

PMID: 40035876 PMC: 11880442. DOI: 10.1007/s00262-025-03976-7.


Recent advances on biogenesis, functions and therapeutic potential of long noncoding RNAs in T cell acute lymphoblastic leukemia.

Kaur P, Sharma P, Bhatia P, Singh M Discov Oncol. 2024; 15(1):729.

PMID: 39612075 PMC: 11607202. DOI: 10.1007/s12672-024-01618-5.


Knockdown of long non-coding RNA SBF2-AS1 inhibits calcium oxalate-induced HK-2 cell injury by regulating the miR-302e/NLRP3 pathway.

Zhu H, Chen Y, Zhong Y, Xie X, Zeng X, Deng W Urolithiasis. 2024; 52(1):113.

PMID: 39105900 DOI: 10.1007/s00240-024-01606-y.


Positioning in 8q24.21 Involved in the Tumorigenesis of Colorectal Cancer by Targeting .

Tian S, Chen M, Jing W, Meng Q, Wu J Protein Pept Lett. 2024; 31(7):544-558.

PMID: 39082173 DOI: 10.2174/0109298665305114240718072029.


Upregulation of the long noncoding RNA GJA9-MYCBP and PVT1 is a potential diagnostic biomarker for acute lymphoblastic leukemia.

Shahamiri K, Alghasi A, Saki N, Teimori H, Abbas Kaydani G, Sheikhi S Cancer Rep (Hoboken). 2024; 7(7):e2115.

PMID: 38994720 PMC: 11240143. DOI: 10.1002/cnr2.2115.


References
1.
Han J, Xiong J, Wang D, Fu X . Pre-mRNA splicing: where and when in the nucleus. Trends Cell Biol. 2011; 21(6):336-43. PMC: 6553873. DOI: 10.1016/j.tcb.2011.03.003. View

2.
Yu H, Lee H, Herrmann A, Buettner R, Jove R . Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer. 2014; 14(11):736-46. DOI: 10.1038/nrc3818. View

3.
Qi P, Du X . The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol. 2012; 26(2):155-65. DOI: 10.1038/modpathol.2012.160. View

4.
Cui M, You L, Ren X, Zhao W, Liao Q, Zhao Y . Long non-coding RNA PVT1 and cancer. Biochem Biophys Res Commun. 2016; 471(1):10-4. DOI: 10.1016/j.bbrc.2015.12.101. View

5.
Wang K, Chang H . Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011; 43(6):904-14. PMC: 3199020. DOI: 10.1016/j.molcel.2011.08.018. View